---
$id: https://graph.org.ai/products/commodity/51352001
$type: Product
source: UNSPSC
code: "51352001"
title: "Demegestone"
class: "51352000"
classTitle: "Estrogen, progestin, or internal contraceptive norpregnenes"
family: "51350000"
familyTitle: "Estrogens and progestins and internal contraceptives"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Demegestone

**UNSPSC Code**: 51352001
**Class**: [Estrogen, progestin, or internal contraceptive norpregnenes](Estrogen, progestin, or internal contraceptive norpregnenes.mdx)
**Family**: [Estrogens and progestins and internal contraceptives](../Estrogens and progestins and internal contraceptives.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic progestin with the molecular formula C21H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6E89AM91SZ, chemically known as 19-norpregna-4,9-diene-3,20-dione, 17-methyl- (8ci)(9ci) but generally known as demegestone, which bears US NIH Compound Identifier 93057. European Medicines Agency schedules Demegestone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06966MIG. The term DEMEGESTONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules demegestone in its Anatomical Therapeutic Chemical (ATC) Classification. DEMEGESTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule demegestone under HS 29372300 and SITC 54153. As of Q4 2014, DEMEGESTONE remains the US FDA Preferred Term for this commodity. Demegestone bears US NLM identifiers UMLS ID C0057362 and NCI Concept Code C76304. SMILES: O=C(C1(C2(C(C3C(=C4C(=CC(=O)CC4)CC3)CC2)CC1)C)C)C.

